Scientific publications

Omalizumab is effective in nonautoimmune urticaria

Ferrer M, Gamboa P, Sanz ML [SP], Goikoetxea MJ [SP], Cabrera-Freitag P [SP], Javaloyes G, Berroa F, Kaplan AP.
Department of Allergy, Clinica Universidad de Navarra Medical School, Pamplona, Spain.

Magazine: The Journal of Allergology and Clinica Immunology

Date: May 1, 2011

Allergology and Immunology Department

We performed an open prospective observational study to assess whether omalizumab is effective treatment of patients with nonautoimmune chronic urticaria who are unresponsive to antihistamines, and in some instances, unresponsive to low-dose corticosteroid and/or cyclosporine.

We included the first 9 consecutive patients with severe nonautoimmune chronic urticaria who fulfilled the aforementioned criteria. The patients were designated “nonautoimmune” by measuring histamine release (1.22; interquartile range [IR] 0-9.9), and CD63 expression (0.62; IR 0-4.4) on incubation of patients’ sera with donor basophils, and all subjects were negative.

CITATION  J Allergy Clin Immunol. 2011 May;127(5):1300-2

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra